AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Eda Ven 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Biovenice Criticure

Salt Composition

Edaravone (1.5mg)

Overview Eda Ven 1.5mg Injection

Edaven 1.5mg injection treats amyotrophic lateral sclerosis (ALS), a neurological disorder causing muscle weakness and functional impairment. This antioxidant medication mitigates nerve cell damage, potentially slowing ALS progression. Administered intravenously by a healthcare provider, it's reserved for patients unable to take oral medication. Follow your physician's prescribed dosage and regimen; if a dose is missed, take it immediately upon recollection. Common side effects include headache, ecchymosis, and gait abnormalities. Injection site reactions (pain, erythema, edema) may occur but are typically transient. Persistent or bothersome symptoms warrant medical consultation. Report any allergic reactions (e.g., pruritus, facial or lingual swelling) immediately, as they necessitate prompt medical intervention.

Uses of Eda Ven 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Eda Ven 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Eda Ven 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Eda Ven 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Eda Ven 1.5mg Injection works:

Eda Ven 1.5mg Injection combats oxidative stress, acting as a neuroprotectant and cognitive enhancer. Its antioxidant properties mitigate neuronal damage from free radicals, thereby slowing the advancement of amyotrophic lateral sclerosis (ALS) symptoms by restoring equilibrium between antioxidants and free radicals within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Eda Ven 1.5mg Injection is uncertain. Medical advice should be sought before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Eda Ven 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Eda Ven 1.5mg Injection with breastfeeding are lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Eda Ven 1.5mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Eda Ven 1.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Eda Ven 1.5mg Injection cautiously, potentially requiring dose modification. Consult a physician for guidance. Data regarding Eda Ven 1.5mg Injection use in such patients is limited. Dosage alteration isn't advised for those with mild to moderate liver dysfunction.

What if you forget to take Eda Ven 1.5mg Injection :

NA

Facts to Know About Eda Ven 1.5mg Injection

LabelValue
Type of Compound Pyrazolone-based compounds
Potential for Dependence None.
Type of Treatment Nervous system medication.
Mechanism of Action Cognitive enhancer

FAQs on Eda Ven 1.5mg Injection

Eda Ven 1.5mg Injection may cause confusion, headache, and gait disturbance as frequently reported side effects. Less frequently observed adverse reactions include skin rashes with itching, respiratory distress manifested as chest tightness, wheezing, and cough (particularly in asthmatics), and the development of fungal infections.
Eda Ven 1.5mg Injection, a liquid solution, is administered intravenously over one hour by a medical professional in a clinic or hospital setting. For the initial 28-day treatment cycle, it's typically injected daily for the first 14 days. Subsequent 28-day cycles involve daily injections for the first 10 days. Dosage frequency is determined by your physician, considering your individual reaction to the medication.
Edaravone 1.5mg injection is indicated for the management of amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease characterized by the gradual deterioration of motor neurons, leading to muscle atrophy and weakness. Edaravone 1.5mg injection functions by mitigating the neuronal damage associated with ALS symptom progression.
Tell your physician or pharmacist about any allergies you have, including to edaravone, other drugs, sodium bisulfite, or any Eda Ven 1.5mg Injection component. Disclose all current and planned medications, vitamins, and supplements to your doctor before starting treatment. Dosage adjustments or close monitoring for adverse reactions may be necessary. Inform your doctor of any history of asthma, current pregnancy or plans for pregnancy, or breastfeeding. Contact your doctor immediately if you conceive while undergoing edaravone therapy.
Research has yet to determine whether ALS is preventable. Nevertheless, understanding associated risk factors may lessen the likelihood of developing the condition. These factors include tobacco use and contact with pesticides and insecticides. Furthermore, evidence indicates a heightened ALS risk among military veterans.
Individuals of Caucasian and non-Hispanic descent exhibit the highest incidence of this disease. Between 5% and 10% of all cases have a hereditary basis, resulting from parental transmission. Onset can occur at any age, though the most frequent appearance of symptoms is between 55 and 75 years of age. A slightly elevated risk exists for men compared to women, a disparity which lessens with increasing age. Research indicates a possible link between military service and a 1.5 to 2-fold increased risk, potentially attributable to exposure to toxins during military operations.
Studies propose a link between toxin exposure in combat or intense physical exertion and a heightened ALS risk among veterans and athletes.
Initial ALS manifestations can involve muscle fasciculations in the limbs or tongue, muscle spasms, muscular rigidity (spasticity), and weakness affecting an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and chewing or swallowing may become challenging. Frequently, the initial symptom is hand or arm weakness, hindering everyday actions like fastening buttons, writing, or operating a key. Alternatively, leg weakness may be the first noticeable sign, leading to gait difficulties, increased tripping, or stumbling.
Eda Ven 1.5mg Injection
509
MRP 620
17% off